Boston Scientific Corp. vs. Treace Medical Concepts, Inc. Common Stock
BSX
Boston Scientific Corp.
$49.01 -2.70%
VS TMCITreace Medical Concepts, Inc. Common Stock
$4.37 +0.69%
Boston Scientific Corp. (BSX) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| BSX | TMCI | |
|---|---|---|
| Market Cap | $73.00 billion | $282.25 million |
| Revenue (TTM) | $21.00 billion | $205.31 million |
| Net Income (TTM) | $3.67 billion | $-59,516,000 |
BSX leads on 3 of 3 size & scale factors.
Valuation
| BSX | TMCI | |
|---|---|---|
| P/E Ratio | 19.84 | — |
| Price / Book | 2.90 | 4.17 |
| Price / Sales | 3.48 | 1.37 |
BSX and TMCI split the valuation factors evenly.
Profitability
| BSX | TMCI | |
|---|---|---|
| Net Margin | 17.47% | -28.99% |
| Return on Equity | 14.57% | -87.86% |
BSX leads on 2 of 2 profitability factors.
Risk & Sentiment
| BSX | TMCI | |
|---|---|---|
| Short Interest | 0.72% | 0.08% |
TMCI leads on 1 of 1 risk & sentiment factors.
Dig deeper: BSX overview, BSX financials, TMCI overview, TMCI financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.